Study of Anti-Müllerian Hormone and Its Relation to the Subsequent Probability of Pregnancy in 112 Patients With Systemic Lupus Erythematosus, Exposed or Not to Cyclophosphamide
Author(s) -
Nathalie Morel,
Anne Bachelot,
Zeina Chakhtoura,
Pascale GhillaniDalbin,
Zahir Amoura,
Lionel Galicier,
O. Aumaître,
JeanCharles Piette,
Jacques Pourrat,
Du Le Thi Huong Boutin,
Karim Sacré,
JeanEmmanuel Kahn,
P. Duhaut,
Dominique Farge,
Camille Françès,
G. Guettrot-Imbert,
JeanRobert Harlé,
Olivier Lambotte,
Véronique Le Guern,
D. Sène,
S. Trad,
Elisabeth Vidal,
F. Sarrot-Reynauld,
Anne Gompel,
MarieLaure Tanguy,
Philippe Touraine,
JeanMarc Lacorte,
Nathalie Costedoat-Chalumeau,
on behalf of the PLUS group
Publication year - 2013
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2013-1235
Subject(s) - medicine , cyclophosphamide , pregnancy , context (archaeology) , anti müllerian hormone , univariate analysis , obstetrics , cohort , interquartile range , ovarian reserve , gynecology , multivariate analysis , hormone , infertility , chemotherapy , genetics , paleontology , biology
Cyclophosphamide is used for renal and major extrarenal involvement in systemic lupus erythematosus (SLE) and is associated with a risk of premature ovarian failure. There are no data available about the relation between anti-Müllerian hormone (AMH) serum levels and the probability of subsequent pregnancy in SLE patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom